The optimal management of pancreatic ductal carcinoma remains poorly defined. Radical resection is possible in about 20–30% of patients, with an overall 5-year survival rate of only 20% [1]. In recent years, perioperative morbidity and mortality have significantly decreased, and different clinical trials have suggested an important role for adjuvant therapy
Cancer of the Exocrine Pancreas: Surgery and Multimodal Treatment
Barugola, Giuliano;Falconi, Massimo;ZARANTONELLO, FABIO REMO;Malleo, Giuseppe;Bassi, Claudio;Pederzoli, Paolo
2009-01-01
Abstract
The optimal management of pancreatic ductal carcinoma remains poorly defined. Radical resection is possible in about 20–30% of patients, with an overall 5-year survival rate of only 20% [1]. In recent years, perioperative morbidity and mortality have significantly decreased, and different clinical trials have suggested an important role for adjuvant therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
